Adam Kadlec is the founder of Rivermark Medical. Rivermark Medical has raised $40M in total funding. Latest round: Series C.
Adam Kadlec is the co-founder and CEO of Rivermark Medical, a Milwaukee-based medical device company. Under his leadership, Rivermark Medical has raised approximately $40 million to develop the FloStent system for benign prostatic hyperplasia (BPH). The company is currently conducting a pivotal clinical trial for its minimally invasive BPH treatment.
Full founder directory · Investor directory · Company funding database · Fundraising library